| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/12/2004 | CN1496360A Imidazolidine derivatives, their preparation, and their use as antinflamatory agent |
| 05/12/2004 | CN1496351A 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 05/12/2004 | CN1496348A 5-cyano-1H-indole derivatives as antagonists of interleukine-8 receptors |
| 05/12/2004 | CN1496271A Method of treating diseases in association with decrease in expression of AOP-1 gene or AOP-1 and remedies for diseases |
| 05/12/2004 | CN1496264A 4-fluoro-N-indan-2-Y1 benzamide and its use as pharmaceutical |
| 05/12/2004 | CN1496255A Inhibition of NF-KB by triterpene compositions |
| 05/12/2004 | CN1495258A Human tissue inhibitor of metalloprotease-4 |
| 05/12/2004 | CN1495198A Analogs of glucagon-like peptide-1 |
| 05/12/2004 | CN1495184A Substituted purine derivative, its preparation method, application and composition containing it |
| 05/12/2004 | CN1495171A Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 05/12/2004 | CN1495170A Substituted pyrazolyl benzsulfamide compound for curing inflammation |
| 05/12/2004 | CN1494920A Soft capsule preparation containing cyclosporin |
| 05/12/2004 | CN1494915A Chinese medicine for curing prolapse of cervicolumbar intervertabral disk |
| 05/12/2004 | CN1149204C 1-heterocycle substd. diarylamines |
| 05/12/2004 | CN1149193C Substituted tricyclic compound |
| 05/12/2004 | CN1149190C Nitric oxide synthase inhibitors |
| 05/12/2004 | CN1149094C Medicated wine for curing traumatic injury |
| 05/12/2004 | CN1149091C Oral Medicine for treating waist. back bone wound |
| 05/12/2004 | CN1149088C Bone growth promoting composition and its use |
| 05/11/2004 | US6734306 N-benzenesulfonyl L-proline compounds as bradykinin antagonists |
| 05/11/2004 | US6734194 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation |
| 05/11/2004 | US6734184 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) |
| 05/11/2004 | US6734183 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound |
| 05/11/2004 | US6733994 Highly expressible genes |
| 05/11/2004 | US6733990 Useful for the treatment of immune, hematologic, fibrotic, hepatic, and respiratory disorders such as asthma using g-protein coupled receptors (gpcr) |
| 05/11/2004 | US6733981 Antibodies to interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 05/11/2004 | US6733743 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
| 05/11/2004 | US6732738 Method to enhance healing of sternum after sternotomy |
| 05/06/2004 | WO2004037829A1 Novel benzoxazole or oxazolopyridine compounds, method for preparing same and pharmaceutical compositions containing same |
| 05/06/2004 | WO2004037817A1 N-oxide compounds |
| 05/06/2004 | WO2004037280A1 Angiogenesis inducer |
| 05/06/2004 | WO2004037274A1 Amine polymers for promoting bone formation |
| 05/06/2004 | WO2004037254A1 Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent |
| 05/06/2004 | WO2004037252A1 A new crystalline form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid |
| 05/06/2004 | WO2004037251A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 05/06/2004 | WO2004037236A1 OSTEOGENESIS PROMOTER CONTAINING β-CRYPTOXANTHIN AS THE ACTIVE INGREDIENT |
| 05/06/2004 | WO2004037184A2 Methods for the treatment of skin disorders |
| 05/06/2004 | WO2004037173A2 Method for treating erectile dysfunction and increasing libido in men |
| 05/06/2004 | WO2004018457A8 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
| 05/06/2004 | WO2004018451A8 Pyridazinone-derivatives as pde4 inhibitors |
| 05/06/2004 | WO2004013629A3 Screening for agents suitable for treatment of leukocyte associated inflammatory diseases |
| 05/06/2004 | WO2004004750A3 Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 05/06/2004 | WO2003105893A3 Probiotic therapies using lactobacillus reuteri |
| 05/06/2004 | WO2003092580A3 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 05/06/2004 | WO2003051365A9 Use of compounds of the benzamide family as immunosuppressant |
| 05/06/2004 | WO2003045316A9 Polynucleotide therapy |
| 05/06/2004 | WO2003005971A8 Tetracycline compounds having target therapeutic activities |
| 05/06/2004 | WO2003004467A3 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 05/06/2004 | WO2002102800A9 5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors |
| 05/06/2004 | WO2002089800A3 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 05/06/2004 | WO2002072098A8 Method of treatment |
| 05/06/2004 | WO2002020512A9 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 05/06/2004 | US20040087800 Spirooxindole derivatives are analgesics for the treatment of chronic pain. |
| 05/06/2004 | US20040087796 Substituted carbazoles as inhibitors of spla2 |
| 05/06/2004 | US20040087792 Tryptase-inhibitors |
| 05/06/2004 | US20040087791 Bis(substituted propynyl)-substituted benzenes, pyridines, pyrimidines, pyrazines, pyridines, furans and pyrroles; e.g., 3,5-bis-(3-(4-aminomethylbenzylaminocarbonyloxy)prop-1-ynyl)--1 -hydroxymethylbenzene |
| 05/06/2004 | US20040087784 Neuronal serine-threonine protein kinase |
| 05/06/2004 | US20040087778 Modified peptides as therapeutic agents |
| 05/06/2004 | US20040087654 Nitric oxide synthase inhibitor phosphate salt |
| 05/06/2004 | US20040087640 Administering by mouth; cyclooxygenase inhibitor; controlling particle size |
| 05/06/2004 | US20040087628 Enzyme inhibitors; antiarthritic agents; psoriasis; viricides; bactericides |
| 05/06/2004 | US20040087624 Analgesics; antiinflammatory agents; immunology; bone disorders; neurodegradation diseases |
| 05/06/2004 | US20040087574 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 05/06/2004 | US20040087566 Enzyme inhibitors; anticancer agents |
| 05/06/2004 | US20040087557 Treating muscle wasting with selective androgen receptor modulators |
| 05/06/2004 | US20040087552 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/06/2004 | US20040087550 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof |
| 05/06/2004 | US20040087548 Anticancer agents and treating immune disorders |
| 05/06/2004 | US20040087538 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
| 05/06/2004 | US20040087524 Agent for postoperative use after removal of bone tumours |
| 05/06/2004 | US20040086988 Enzyme catalyst; polypeptides; crystal structure |
| 05/06/2004 | US20040086942 Comprises peptide mimetic which competes for binding site of immunoglobulin receptor and prevents and treats allergic disorders |
| 05/06/2004 | US20040086904 Identifying modulators which suppress synthesis of secreted and/or membrane protein for prevention and treatment of allergic,inflammatory, skin, cardiovascular, nervous system and cancer disorders |
| 05/06/2004 | US20040086899 Compromises nuclelotide sequences coding polypeptides associated with elongation of fatty acid chains for treatment and prevention of skin, cardiovascular, inflammatory, gastrointestinal, respiratory system and bone disorders |
| 05/06/2004 | US20040086877 Multi-mode directi memory access controller and method |
| 05/06/2004 | US20040086522 Strategies to prevent autoimmune disease by vaccination with vaccines based upon Epstein-Barr virus |
| 05/06/2004 | US20040086500 Murabutide, an analog of muramyl dipeptide, induces the production of cytokines or other factors not identified to date, which have a suppressor activity on HIV |
| 05/06/2004 | EP1416052A1 Process for producing 1,4-dihydroxy-2-naphthoic acid |
| 05/06/2004 | EP1415987A1 Nitrogenous aromatic ring compounds |
| 05/06/2004 | EP1415773A1 Gripper |
| 05/06/2004 | EP1414964A2 Vegf isoform |
| 05/06/2004 | EP1414937A1 Hops extracts, method for the production and use |
| 05/06/2004 | EP1414862A1 Anti-idiotypic antibodies of hla class i molecules and the use thereof in the preparation of compositions that are designed to inhibit vascular activation |
| 05/06/2004 | EP1414858A2 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses |
| 05/06/2004 | EP1414856A2 Modified calcitonin |
| 05/06/2004 | EP1414849A2 Immune-modulating peptide |
| 05/06/2004 | EP1414841A1 Oligonucleotide-containing pharmacological compositions and their use |
| 05/06/2004 | EP1414825A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 05/06/2004 | EP1414817A1 Substituted isoindoles and e use thereof |
| 05/06/2004 | EP1414812A1 Hydroxamic acid derivatives |
| 05/06/2004 | EP1414810A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 05/06/2004 | EP1414804A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors |
| 05/06/2004 | EP1414802A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 05/06/2004 | EP1414790A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
| 05/06/2004 | EP1414778A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 05/06/2004 | EP1414500A2 Akt and regulation of ra synovial fibroblast apoptosis |
| 05/06/2004 | EP1414492A1 Method for treating multiple myeloma |
| 05/06/2004 | EP1414486A2 Use of glp-2 in combination with another therapeutic agent in bone-related and nutrition-related disorders |
| 05/06/2004 | EP1414481A2 Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 05/06/2004 | EP1414471A2 Therapeutic agents comprising pro-apoptotic proteins |